en

PRODUCT DETAIL

Mektovi 15 mg filmom obalené tablety

Code 9992C
MA number EU/1/18/1315/002
Product Form: tbl flm 168x15 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Pierre Fabre Médicament, France
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EE03 Binimetinib
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.09.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.06.2024
eu-flag.png sk-flag.png